Founder of Dimension, a venture capital firm that closed $800M Fund III investing at the frontiers of science and compute: silicon, ML infrastructure, world models, and next-gen medicines.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Convergence of AI, advanced compute, and biology enables new company models: full-stack drug development, world models, and neolabs; Dimension invests across silicon, ML infrastructure, and next-gen medicines.